Overexpression of the pituitary tumor transforming gene upregulates metastasis in malignant neoplasms of the human salivary glands

Liu,Jia; Wang,Yuguang; He,Hong; Jin,Wulong; Zheng,Rong

doi:10.3892/etm.2015.2566

Overexpression of the pituitary tumor transforming gene upregulates metastasis in malignant neoplasms of the human salivary glands

Authors:
- Jia Liu
- Yuguang Wang
- Hong He
- Wulong Jin
- Rong Zheng
View Affiliations

Affiliations: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei‑MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, Hubei 430079, P.R. China, Department of Diagnostic Imaging, The Second Affiliated Hospital, Inner Mongolia Medical University, Hohhot, Inner Mongolia 010030, P.R. China, Department of Stomatology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010050, P.R. China
Published online on: June 10, 2015 https://doi.org/10.3892/etm.2015.2566
Pages: 763-768

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Salivary gland malignant neoplasms (SGMNs) represent a group of malignant solid tumors with heterogeneity in their cellular make‑up, which causes difficulty with regard to the immunohistochemical confirmation of their cytological features. In the present study, overexpression of the pituitary tumor transforming gene (PTTG) was evaluated in human mucoepidermoid carcinoma specimens with a submaxillary salivary gland origin by immunohistochemical analysis, western blot analysis and reverse transcription quantitative polymerase chain reaction. In addition, a SGMN cell line was constructed, namely A‑253 PTTG (+), which overexpressed PTTG. Subsequently, the regulatory role of PTTG in the proliferation and migration of A‑253 cells was investigated. The immunohistochemical results demonstrated that there was a higher rate of PTTG‑positive cells in the SGMN tissues when compared with the control submaxillary salivary gland tissues. Furthermore, PTTG expression at a mRNA and protein level was significantly higher in the SGMN specimens when compared with the control specimens. In addition, the rates of proliferation and migration of the A‑253 PTTG (+) cells were significantly higher compared with the A‑253 PTTG (‑) cells. Therefore, PTTG was demonstrated to play an important role in SGMN cell proliferation and migration, and may subsequently be a notable marker for SGMN diagnosis and a potential target for anticancer therapy.

View Figures

View References

1	Lopes MA, Santos GC and Kowalski LP: Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck. 20:699–706. 1998. View Article : Google Scholar : PubMed/NCBI
2	Hocwald E, Korkmaz H, Yoo GH, Adsay V, Shibuya TY, Abrams J and Jacobs JR: Prognostic factors in major salivary gland cancer. Laryngoscope. 111:1434–1439. 2001. View Article : Google Scholar : PubMed/NCBI
3	Speight PM and Barrett AW: Prognostic factors in malignant tumours of the salivary glands. Br J Oral Maxillofac Surg. 47:587–593. 2009. View Article : Google Scholar : PubMed/NCBI
4	Rapidis AD, Givalos N, Gakiopoulou H, Stavrianos SD, Faratzis G, Lagogiannis GA, Katsilieris I and Patsouris E: Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients. Oral Oncol. 43:130–136. 2007. View Article : Google Scholar : PubMed/NCBI
5	Thompson L: World Health Organization classification of tumours: Pathology and genetics of head and neck tumours. Ear Nose Throat J. 85:742006.PubMed/NCBI
6	Etges A, Nunes FD, Ribeiro KC and Araújo VC: Immunohistochemical expression of retinoblastoma pathway proteins in normal salivary glands and in salivary gland tumours. Oral Oncol. 40:326–331. 2004. View Article : Google Scholar : PubMed/NCBI
7	Shang J, Shui Y, Sheng L, Wang K, Hu Q and Wei Q: Epidermal growth factor receptor and human epidermal growth receptor 2 expression in parotid mucoepidermoid carcinoma: Possible implications for targeted therapy. Oncol Rep. 19:435–440. 2008.PubMed/NCBI
8	Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE and Driemel O: Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology. 53:567–577. 2008. View Article : Google Scholar : PubMed/NCBI
9	Senft E, Lemound J, Stucki-Koch A, Gellrich NC, Kreipe H and Hussein K: Expression of cyclin-dependent kinase inhibitor 2A 16, tumour protein 53 and epidermal growth factor receptor in salivary gland carcinomas is not associated with oncogenic virus infection. Int J Oral Sci. 7:18–22. 2015. View Article : Google Scholar : PubMed/NCBI
10	Pei L and Melmed S: Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol. 11:433–441. 1997. View Article : Google Scholar : PubMed/NCBI
11	Zou H, McGarry TJ, Bernal T and Kirschner MW: Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science. 285:418–422. 1999. View Article : Google Scholar : PubMed/NCBI
12	Jallepalli PV, Waizenegger IC, Bunz F, Langer S, Speicher MR, Peters JM, Kinzler KW, Vogelstein B and Lengauer C: Securin is required for chromosomal stability in human cells. Cell. 105:445–457. 2001. View Article : Google Scholar : PubMed/NCBI
13	Solbach C, Roller M, Fellbaum C, Nicoletti M and Kaufmann M: PTTG mRNA expression in primary breast cancer: A prognostic marker for lymph node invasion and tumor recurrence. Breast. 13:80–81. 2004. View Article : Google Scholar : PubMed/NCBI
14	Wen CY, Nakayama T, Wang AP, Nakashima M, Ding YT, Ito M, Ishibashi H, Matsuu M, Shichijo K and Sekine I: Expression of pituitary tumor transforming gene in human gastric carcinoma. World J Gastroenterol. 10:481–483. 2004.PubMed/NCBI
15	Honda S, Hayashi M, Kobayashi Y, Ishikawa Y, Nakagawa K and Tsuchiya E: A role for the pituitary tumor-transforming gene in the genesis and progression of non-small cell lung carcinomas. Anticancer Res. 23:3775–3782. 2003.PubMed/NCBI
16	Zhou C, Liu S, Zhou X, Xue L, Quan L, Lu N, Zhang G, Bai J, Wang Y, Liu Z, et al: Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin/TCF pathway in human esophageal squamous cell carcinoma. Int J Cancer. 113:891–898. 2005. View Article : Google Scholar : PubMed/NCBI
17	Ramaswamy S, Ross KN, Lander ES and Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet. 33:49–54. 2003. View Article : Google Scholar : PubMed/NCBI
18	Shibata Y, Haruki N, Kuwabara Y, Nishiwaki T, Kato J, Shinoda N, Sato A, Kimura M, Koyama H, Toyama T, et al: Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol. 32:233–237. 2002. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Li Z, Tian T, Lv F, Chang Y, Wang X, Zhang L, Li X, Li L, Ma W, Wu J, et al: Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression. PLoS One. 8:e592032013. View Article : Google Scholar : PubMed/NCBI
21	Szymczak-Workman AL, Vignali KM and Vignali DA: Verification of 2A peptide cleavage. Cold Spring Harb Protoc. 2012:255–257. 2012. View Article : Google Scholar : PubMed/NCBI
22	Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF and Vignali DA: Correction of multi-gene deficiency in vivo using a single ‘self-cleaving’ 2A peptide-based retroviral vector. Nat Biotechnol. 22:589–594. 2004. View Article : Google Scholar : PubMed/NCBI
23	Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M and Melmed S: Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet. 355:716–719. 2000. View Article : Google Scholar : PubMed/NCBI
24	Wen CY, Nakayama T, Wang AP, et al: Expression of pituitary tumor transforming gene in human gastric carcinoma. World J Gastroenterol. 10:481–483. 2004.PubMed/NCBI
25	Ramaswamy S, Ross KN, Lander ES and Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet. 33:49–54. 2003. View Article : Google Scholar : PubMed/NCBI